Use of 2-(N-2,6-dichlorophenyl-N-allylamino)-2-imidazoline as cytoprotective agent

US4871760A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Dietrich Arndts · Appenheim, DE
• Gunter Schingnitz · Bad Kreuznach, DE
• Ilse Streller · Stromberg, DE
• Alexander Walland · Ingelheim am Rhein, DE

Key dates

• Filing date: Jun 18, 1987
• Grant date: Oct 3, 1989
• Expiry date: Jun 18, 2007

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of 2-[N-(2,6-dichlorophenyl)-N-allylamino]-2-imidazoline as a cytoprotective agent.